A global research university in Boston built around experiential co-op learning, with research spanning health, AI, security, and sustainability.
Northeastern University / Broad Institute / KAIST / EPFL / HITS Inc.
Released August 2, 2026
Enzyme-substrate specificity prediction by end-to-end co-folding, with no predefined binding pocket. AUROC 0.766 on unseen enzymes and substrates.
Northeastern University / Hunter College, CUNY / The Graduate Center, CUNY
Released July 22, 2026
Molecule generation conditioned on single-cell transcriptomes, designing cell-type-specific compounds that revert diseased cell states.
De novo protein binder design that recasts structure-predictor confidence as an energy function, replacing ipTM as the hallucination objective.
Spatial transcriptomics prediction from H&E whole-slide images. One generative checkpoint covers 38,984 genes and 17 organs without fine-tuning.
Autoregressive graph transformer generating molecules as node and edge token sequences, fine-tunable for goal-directed design and property prediction.
Alexion, AstraZeneca Rare Disease / AstraZeneca / Northeastern University / Santa Fe Institute
Released December 15, 2024
Disease embeddings learned from human genetic evidence and phenotype ontologies, placing rare and common conditions in one mechanistic vector space.
McGill University / Shanghai Jiao Tong University / Mila / Université de Montréal / Hong Kong University of Science and Technology / Institute for Protein Design / Yale University / Northeastern University / Broad Institute / MIT / Google DeepMind
Released November 10, 2024
De novo enzyme design conditioned on the reaction to be catalysed: substrate and product SMILES in, catalytic pocket, enzyme, and docked complex out.
Zhejiang University / University of Adelaide / Northeastern University / MIT / Ant Group
Released October 12, 2024
Predicts binding free energy change (ΔΔG) at protein-protein interfaces by scoring bound and unbound states with an inverse folding model.